Want to see TSE:DHB full AI Analyst Report?
Delivra Health Brands (DHB) Ratios
Delivra Health Brands Ratios
TSE:DHB's free cash flow for Q3 2026 was $-844.00K. For the 2026 fiscal year, TSE:DHB's free cash flow was increased by $0.00 and operating cash flow was $-844.00K. See a summary of the company’s cash flow.
| Ratios | Jun 26 | Sep 25 | Sep 24 | Sep 23 | Sep 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.62 | 2.69 | 2.85 | 1.45 | 1.14 |
| Quick Ratio | 1.83 | 1.91 | 2.37 | 1.03 | 0.80 |
| Cash Ratio | 1.08 | 0.93 | 1.37 | 0.50 | 0.17 |
| Solvency Ratio | -0.47 | 0.01 | 0.45 | 0.16 | -0.60 |
| Operating Cash Flow Ratio | -0.24 | -0.21 | 0.25 | -0.20 | -0.68 |
| Short-Term Operating Cash Flow Coverage | -1.80 | -2.45 | 3.12 | -4.30 | -10.19 |
| Net Current Asset Value | $ 2.22M | $ 4.21M | $ 3.90M | $ 744.00K | $ -727.00K |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.35 | 0.22 | 0.20 | 0.19 | 0.18 |
| Debt-to-Equity Ratio | 1.08 | 0.50 | 0.39 | 0.58 | 0.62 |
| Debt-to-Capital Ratio | 0.52 | 0.33 | 0.28 | 0.37 | 0.38 |
| Long-Term Debt-to-Capital Ratio | 0.48 | 0.30 | 0.26 | 0.33 | 0.33 |
| Financial Leverage Ratio | 3.12 | 2.27 | 1.94 | 3.12 | 3.43 |
| Debt Service Coverage Ratio | -3.93 | 1.00 | 5.73 | 2.78 | -3.97 |
| Interest Coverage Ratio | -12.63 | -7.13 | -4.20 | -5.45 | -9.47 |
| Debt to Market Cap | 0.77 | 0.38 | 0.24 | 0.77 | 0.28 |
| Interest Debt Per Share | 0.08 | 0.07 | 0.08 | 0.09 | 0.11 |
| Net Debt to EBITDA | 0.22 | -2.78 | -0.92 | -0.55 | -0.24 |
| Profitability Margins | |||||
| Gross Profit Margin | 38.34% | 50.70% | 51.70% | 35.68% | 5.96% |
| EBIT Margin | -23.85% | -6.29% | 8.44% | 0.67% | -78.31% |
| EBITDA Margin | -23.54% | 3.19% | 19.02% | 14.26% | -52.28% |
| Operating Profit Margin | -23.85% | -6.29% | -5.74% | -13.92% | -73.87% |
| Pretax Profit Margin | -26.12% | -8.90% | 7.08% | -1.88% | -86.12% |
| Net Profit Margin | -26.12% | -8.90% | 7.08% | -1.88% | -86.12% |
| Continuous Operations Profit Margin | -26.12% | -8.90% | 7.08% | -1.88% | -86.12% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 109.52% | 141.50% | -123.38% | 13.50% | 116.58% |
| Return on Assets (ROA) | -32.53% | -12.39% | 8.71% | -1.74% | -60.50% |
| Return on Equity (ROE) | -101.35% | -28.07% | 16.87% | -5.43% | -207.80% |
| Return on Capital Employed (ROCE) | -48.07% | -13.91% | -10.17% | -26.76% | -119.19% |
| Return on Invested Capital (ROIC) | -44.40% | -13.24% | -9.83% | -25.50% | -109.71% |
| Return on Tangible Assets | -32.53% | -12.39% | 9.89% | -2.27% | -88.61% |
| Earnings Yield | -72.10% | -21.62% | 10.22% | -7.28% | -92.48% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.63 | 4.00 | 4.20 | 3.57 | 4.76 |
| Payables Turnover | 5.04 | 4.93 | 8.42 | 2.87 | 2.14 |
| Inventory Turnover | 2.55 | 2.39 | 4.05 | 2.79 | 3.45 |
| Fixed Asset Turnover | 0.00 | 495.19 | 120.17 | 54.70 | 30.14 |
| Asset Turnover | 1.25 | 1.39 | 1.23 | 0.93 | 0.70 |
| Working Capital Turnover Ratio | 1.68 | 2.29 | 3.04 | 5.77 | 4.59 |
| Cash Conversion Cycle | 149.75 | 169.86 | 133.81 | 106.23 | 11.64 |
| Days of Sales Outstanding | 78.89 | 91.18 | 86.93 | 102.29 | 76.69 |
| Days of Inventory Outstanding | 143.30 | 152.77 | 90.23 | 130.98 | 105.87 |
| Days of Payables Outstanding | 72.44 | 74.09 | 43.34 | 127.04 | 170.91 |
| Operating Cycle | 222.19 | 243.95 | 177.16 | 233.27 | 182.55 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.02 | -0.03 | 0.03 | -0.04 | -0.18 |
| Free Cash Flow Per Share | -0.02 | -0.03 | 0.03 | -0.04 | -0.18 |
| Dividend Paid and CapEx Coverage Ratio | 0.00 | 0.00 | 0.00 | -26.54 | -201.86 |
| Capital Expenditure Coverage Ratio | 0.00 | 0.00 | 0.00 | -26.54 | -201.86 |
| Operating Cash Flow Coverage Ratio | -0.26 | -0.36 | 0.37 | -0.56 | -2.11 |
| Operating Cash Flow to Sales Ratio | -0.07 | -0.06 | 0.06 | -0.11 | -0.55 |
| Free Cash Flow Yield | -20.38% | -13.70% | 8.82% | -44.69% | -58.89% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -1.39 | -4.86 | 9.78 | -13.73 | -1.08 |
| Price-to-Sales (P/S) Ratio | 0.36 | 0.41 | 0.69 | 0.26 | 0.93 |
| Price-to-Book (P/B) Ratio | 1.41 | 1.30 | 1.65 | 0.75 | 2.25 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -4.91 | -7.30 | 11.34 | -2.24 | -1.70 |
| Price-to-Operating Cash Flow Ratio | -4.91 | -7.30 | 11.34 | -2.32 | -1.71 |
| Price-to-Earnings Growth (PEG) Ratio | -0.02 | 0.02 | -0.02 | 0.14 | 0.02 |
| Enterprise Value Multiple | -1.32 | 10.11 | 2.72 | 1.26 | -2.02 |
| Enterprise Value | 2.68M | 4.31M | 6.40M | 1.76M | 8.60M |
| EV to EBITDA | -1.32 | 10.11 | 2.72 | 1.26 | -2.02 |
| EV to Sales | 0.31 | 0.32 | 0.52 | 0.18 | 1.06 |
| EV to Free Cash Flow | -4.21 | -5.72 | 8.46 | -1.56 | -1.93 |
| EV to Operating Cash Flow | -4.21 | -5.72 | 8.46 | -1.62 | -1.94 |
| Tangible Book Value Per Share | 0.07 | 0.14 | 0.14 | 0.04 | -0.01 |
| Shareholders’ Equity Per Share | 0.07 | 0.14 | 0.18 | 0.13 | 0.13 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.28 | 0.45 | 0.43 | 0.39 | 0.32 |
| Net Income Per Share | -0.07 | -0.04 | 0.03 | -0.01 | -0.28 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.10 | 1.41 | 0.84 | -2.79 | 1.10 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.62 | 0.48 | 0.34 | 0.42 | 0.60 |
| Stock-Based Compensation to Revenue | 0.00 | 0.02 | 0.00 | 0.02 | 0.04 |
| Income Quality | 0.28 | 0.63 | 0.86 | 5.91 | 0.63 |
Currency in CAD
